We are live on ! Find out more
OCM

Orser Capital Management Portfolio holdings

AUM $202M
1-Year Est. Return 32.65%
This Fund
S&P 500
This Quarter Est. Return
+3.56%
1 Year Est. Return
+32.65%
3 Year Est. Return
+122.2%
5 Year Est. Return
+162.36%
10 Year Est. Return
AUM
$154M
AUM Growth
-$3.99M
Cap. Flow
-$8.92M
Cap. Flow %
-5.8%
Top 10 Hldgs %
31.06%
Holding
101
New
12
Increased
23
Reduced
34
Closed
18

Top Sells

Rank Stock Value
1
EW icon
Edwards Lifesciences
EW
+$4.37M
2
COR
Coresite Realty Corporation
COR
+$2.56M
3
CLX icon
Clorox
CLX
+$2.39M
4
PFE icon
Pfizer
PFE
+$2.08M
5
MDT icon
Medtronic
MDT
+$2.06M

Sector Composition

Rank Sector Weight
1 Miscellaneous 31.03%
2 Technology 24.12%
3 Healthcare 11.23%
4 Consumer Staples 8.93%
5 Financials 7.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TXN icon
76
Texas Instruments
TXN
$241B
$302K 0.2%
1,600
-200
-11% -$34.7K
FDMO icon
77
Fidelity Momentum Factor ETF
FDMO
$887M
$283K 0.18%
6,305
JBHT icon
78
JB Hunt Transport Services
JBHT
$25.6B
$252K 0.16%
1,500
SNA icon
79
Snap-on
SNA
$19.4B
$243K 0.16%
+1,053
New +$207K
ORLY icon
80
O'Reilly Automotive
ORLY
$68.9B
$238K 0.15%
7,050
CORP icon
81
PIMCO Investment Grade Corporate Bond Index Exchange-Traded Fund
CORP
$1.33B
$227K 0.15%
+2,035
New +$231K
WDAY icon
82
Workday
WDAY
$46B
$224K 0.15%
900
RSP icon
83
Invesco S&P 500 Equal Weight ETF
RSP
$98.3B
$222K 0.14%
+1,565
New +$211K
ADSK icon
84
Autodesk
ADSK
$47.3B
-2,100
Closed -$641K
ARKG icon
85
ARK Genomic Revolution ETF
ARKG
$2B
-9,760
Closed -$910K
CLX icon
86
Clorox
CLX
$10.5B
-11,823
Closed -$2.39M
CRSP icon
87
CRISPR Therapeutics
CRSP
$5.01B
-1,360
Closed -$208K
DKNG icon
88
DraftKings
DKNG
$12.2B
-21,630
Closed -$1.01M
EW icon
89
Edwards Lifesciences
EW
$49.4B
-47,875
Closed -$4.37M
INTC icon
90
Intel
INTC
$513B
-13,709
Closed -$683K
LHX icon
91
L3Harris
LHX
$46.5B
-1,480
Closed -$280K
MDT icon
92
Medtronic
MDT
$120B
-17,572
Closed -$2.06M
MRK icon
93
Merck
MRK
$355B
-13,291
Closed -$1.04M
NOC icon
94
Northrop Grumman
NOC
$75.5B
-5,889
Closed -$1.79M
PFE icon
95
Pfizer
PFE
$157B
-56,640
Closed -$2.08M
PSQ icon
96
ProShares Short QQQ
PSQ
$777M
-2,803
Closed -$202K
QQQ icon
97
Invesco QQQ Trust
QQQ
$474B
-1,098
Closed -$344K
SEDG icon
98
SolarEdge
SEDG
$2.17B
-5,415
Closed -$1.73M
SH icon
99
ProShares Short S&P500
SH
$920M
-27,645
Closed -$1.99M
VGM icon
100
Invesco Trust Investment Grade Municipals
VGM
$519M
-64,200
Closed -$848K

Similar funds

Orser Capital Management's Q1 2021 Portfolio in Review

As of Q1 2021, Orser Capital Management held 101 positions worth $154M, down 2.5% from $158M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Orser Capital Management withdrew a net $8.92M in Q1 2021, closing 18 positions and reducing 34 holdings. Its most notable exit was Edwards Lifesciences, an estimated $4.37M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 31% of assets, up from 21% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Orser Capital Management opened a new position in Vanguard S&P 500 Value ETF worth $2.25M.

  • Orser Capital Management's largest Q1 2021 buy was Vanguard S&P 500 Value ETF: 16,482 shares worth $2.25M.
  • Orser Capital Management added most to State Street Consumer Staples Select Sector SPDR ETF in Q1 2021, an estimated $1.31M increase.
  • Orser Capital Management's biggest Q1 2021 reduction was Vanguard Short-Term Treasury ETF, cutting an estimated $1.17M.
  • Orser Capital Management fully exited Edwards Lifesciences in Q1 2021, selling an estimated $4.37M.
  • Orser Capital Management's ten largest holdings make up 31% of its $154M portfolio in Q1 2021.
  • Orser Capital Management opened 12 new positions and closed 18 in Q1 2021.
  • Orser Capital Management's portfolio value fell 2.5% quarter-over-quarter to $154M.

Based on Orser Capital Management's 13F filing for Q1 2021, filed 10 May 2021.